IBCCES is the global leader in training and certification for healthcare professionals, educators and corporate partners who work with individuals with autism and other cognitive disorders. Our reach extends to more than 2 million people in all 50 states and over 70 countries around the globe. IBCCES Member Learning Community is provided as a free service to all IBCCES members who have completed one or more of our training and certification programs.
CAR-T cell researchers at Mayo Clinic optimistic about future of treating blood cancers
September 23, 2023
ROCHESTER, Minn. — Survival outcomes using chimeric antigen receptor-T cell therapy (CAR-T cell therapy) continue to be impressive for patients with some blood cancers. “Five years ago, the survival rate for people with blood cancers was 10% to 15%. Nowadays, we are seeing a survival rate of 40%. The job is not done yet,” says Mohamed Kharfan Dabaja, M.D., a hematologist and director of blood marrow and transplantation and cellular therapies at Mayo Clinic Comprehensive…
Powered by WPeMatico